Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.3.1.900
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2015
Dec. 31, 2014
Current assets:    
Cash and cash equivalents [note 5] $ 34,310 $ 27,897
Restricted cash [note 5]   251
Short-term investments [note 5] 20,876 19,160
Interest receivable 111 113
Amounts receivable 14 5,676
Prepaid expenses 1,987 2,165
Other current assets [note 8]   499
Total current assets 57,298 55,761
Restricted cash [note 5] 272  
Property and equipment, net [note 6] 602 257
Other assets [note 8] 37 273
Total assets 58,209 56,291
Current liabilities:    
Accounts payable 1,343 72
Accrued liabilities other 641 863
Accrued clinical liabilities 9,966 13,462
Accrued compensation 1,267 1,333
Current portion of long-term obligations [note 12] 52 236
Lease termination liability [note 7] 1,250 3,250
Deferred collaboration revenue [note 4] 5,040  
Warrant liability [note 5 and note 10] 1,105 3,002
Total current liabilities 20,664 22,218
Long-term obligations, less current portion [note 12] 105 14
Total liabilities $ 20,769 $ 22,232
Commitments and contingencies [note 4 and note 12]
Stockholders' equity:    
Common stock, $0.001 par value, 75,000,000 shares authorized, 29,846,991 and 22,630,652 issued at December 31, 2015 and December 31, 2014, respectively, and 29,812,998 and 22,621,426 outstanding at December 31, 2015 and December 31, 2014, respectively $ 29 $ 22
Additional paid-in capital 211,590 191,373
Accumulated deficit (176,811) (159,958)
Accumulated other comprehensive income 2,632 2,622
Total stockholders' equity 37,440 34,059
Total liabilities and stockholders' equity $ 58,209 $ 56,291